IBS-D -- From Diagnosis to Management

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome
Advertisements

Multimodal Management of Opioid-Induced Constipation
Presenting with IBS symptoms, baseline assessment.
Latest Advances in HCM.
COPD by the Guidelines.
Incorporating New Therapies in IBS-C
iPad Instructions iPad Instructions Polling Question.
Pathophysiology of Irritable Bowel Syndrome
Allergy Testing in Children
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
A CASE CHALLENGE IN HFrEF:
The Nurse View.
The Patient Journey to Remission in MDD: A Collaborative Approach
Understanding the Many Faces of Pseudobulbar Affect
Patient 1: 53-Year-Old Man With CVD Risk Factors
Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.
The Latest Data on Oral Prostacyclin Therapy in PAH
Seasonal Allergic Rhinitis
Case Challenges in Chronic Migraine
Update on IBS and CIC Abstracts and Insight From DDW 2014
What Would You Do in This Case of MDD?
Updates in Pyruvate Kinase Deficiency
IL-17 Inhibitors in the Management of Psoriatic Disease
Addressing Disease Burden in Asthma
A Focus on Polycythemia Vera for Nurse Practitioners and Physician Assistants.
Managing Depression in Bipolar I Disorder
PAH in Adults CHEST Guideline and Expert Panel Report: Grading of Evidence
Are We Closer to Personalized Medicine in MS?
Approaches to the Patient With a Runny Nose
Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Rome IV: What Has Changed? Rome IV IBS Subtypes.
Examining the Latest Evidence in PAH
Ask the Experts.
Evolving Treatment Landscape for PsA
ADVANCED PARKINSON'S DISEASE:
Advancing the Treatment of IBD With Biologics
Best Practices in the Identification and Management of Alzheimer Agitation.
Personalizing Management in the Care of Patients With Advanced Sarcoma
Program Overview. Major Depressive Disorder: The Challenging Patient and the Goal of Recovery.
The Evolving Treatment Landscape in Atopic Dermatitis
When Is Intrathecal Drug Delivery Appropriate?
Understanding and Addressing the Needs of Patients With AD
Implications of Emerging Treatments for Beta-Thalassemia
Challenges in Severe Asthma
EGPA.
New ELN Recommendations
Patient Questions and Expert Answers in Psoriasis:
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Critical Decision Points in Insomnia
Program Goals Background: Anticoagulation in Patients With VTE.
Practical Strategies to Guideline-Recommended Biomarker Testing in NSCLC.
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
Clinical Challenges and Updates in Managing Seizure Clusters
Patient Stories in PAH: Sequential Therapy in a FC II Patient
When Is Intrathecal Drug Delivery Appropriate?
Prostacyclin Pathway Agents in Action
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Issues in Patients With Severe Epilepsy
AMD Therapy: Where Are We Now and Where Are We Going?
Irritable Bowel Syndrome (IBS)
Binge Eating Disorder.
Evaluating Success of Current Treatments for HCM
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Merging the Art and Science of Managing nOH in Clinical Practice
The Building Blocks of Homocystinuria and Homocysteinemia Management
Challenges and Emerging Solutions in Anemia Management Explored
Widening the Options for Major Depressive Disorder
Ask the Psoriasis Expert
Motor Fluctuations in PD
Presentation transcript:

IBS-D -- From Diagnosis to Management

Snapshot of IBS-D

The Diagnostic Challenges of IBS-D

Rome IV Diagnostic Criteria for IBS

Rome IV Diagnostic Testing Recommendations

Practical Approach to the Workup

Key Components of the Patient History

Diagnostic Approach

Emerging Biomarkers

IBS-D Treatment Options

Low-FODMAP Diet vs Australian Diet

A Low FODMAP Diet vs Modified NICE Guidelines in US Adults With IBS-D

Gluten-Free Diet

Probiotics Putative Mechanisms of Action

Pharmacologic Therapies

Loperamide in IBS-D

Antispasmodics

Global Relief of IBS Symptoms With TCAs or SSRIs

Bile Acid Sequestrants

Eluxadoline for IBS-D

Safety of Eluxadoline in Patients With IBS-D

Rifaximin

Repeat Treatment With Rifaximin TARGET 3

Alosetron for IBS-D

Case 5-Year History of Symptoms

Abbreviations

Abbreviations (cont)